Search

Author/Creator Doubre, Helene

1. Lorlatinib for advanced anaplastic lymphoma kinase–positive non–small cell lung cancer: Results of the IFCT-1803 LORLATU cohort. (May 2022)

Authors:
Baldacci, Simon; Besse, Benjamin; Avrillon, Virginie; Mennecier, Bertrand; Mazieres, Julien; Dubray-Longeras, Pascale; Cortot, Alexis B.; Descourt, Renaud; Doubre, Helene; Quantin, Xavier; Duruisseaux, Michael; Monnet, Isabelle; Moro-Sibilot, Denis; Cadranel, Jacques; Clément-Duchêne, Christelle;...
Journal:
European journal of cancer
Issue:
Volume 166(2022)
Page Start:
51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018. (April 2023)

Authors:
Bylicki, Olivier; Tomasini, Pascale; Radj, Gervais; Guisier, Florian; Monnet, Isabelle; Ricordel, Charles; Bigay-Game, Laurence; Geier, Margaux; Chouaid, Christos; Daniel, Catherine; Swalduz, Aurelie; Toffart, Anne-Claire; Doubre, Helene; Peloni, Jean-Michel; Moreau, Diane; Subtil, Fabien; Grella...
Journal:
European journal of cancer
Issue:
Volume 183(2023)
Page Start:
38
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search